LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...
Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option ...
Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...